Tissue-and liquid-based biomarkers in prostate cancer precision medicine

J Meehan, M Gray, C Martínez-Pérez, C Kay… - Journal of personalized …, 2021 - mdpi.com
Worldwide, prostate cancer (PC) is the second-most-frequently diagnosed male cancer and
the fifth-most-common cause of all cancer-related deaths. Suspicion of PC in a patient is …

[HTML][HTML] N-Acetylated Monosaccharides and Derived Glycan Structures Occurring in N-and O-Glycans During Prostate Cancer Development

T Bertok, E Jane, M Hires, J Tkac - Cancers, 2024 - mdpi.com
Post-translational modifications of proteins play an important role in their stability, solubility
and in vivo function. Also, for several reasons, such as the Golgi fragmentation during …

SPR biosensing: Cancer diagnosis and biomarkers quantification

S Swami, F Kayenat, S Wajid - Microchemical Journal, 2024 - Elsevier
Cancer is a leading cause of mortality and morbidity globally, with an estimated 10 million
cancer-related fatalities and 19 million new cases in 2020 alone. Despite remarkable …

[HTML][HTML] Nutritional Supplement with Fermented Soy in Patients Under Active Surveillance for Low-Risk or Intermediate-Risk Prostate Cancer: Results from the …

H Van der Eecken, D De Cock, E Roussel, A Giesen… - Cancers, 2024 - mdpi.com
Abstract Background/Objectives: To investigate the effect of a fermented soy supplement
during 18 months in patients under active surveillance (AS) for low-risk and selected …

[PDF][PDF] The immune microenvironment in mantle cell lymphoma: Targeted liquid and spatial proteomic analyses

L Lokhande - 2023 - portal.research.lu.se
The immune microenvironment in mantle cell lymphoma Targeted liquid and spatial proteomic
analyses Lokhande, Lavanya Page 1 The immune microenvironment in mantle cell lymphoma …

Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma

L Lokhande, V Kuci Emruli, CW Eskelund… - Cancer …, 2022 - Wiley Online Library
Background The possibility to monitor patient's serum proteome during treatment can
provide deepened understanding of the biology associated with response to specific drugs …

Intermediate-risk Prostate Cancer—A Sheep in Wolf's Clothing?

I Heidegger, FC Hamdy, RCN van den Bergh… - European Urology …, 2023 - Elsevier
This case-based discussion describes a 65-year-old man newly diagnosed with
International Society of Urological Pathology (ISUP) grade 2 prostate cancer (PCa) …

Utilizing Prostate Specific Antigen Density to Enhance Diagnostic Accuracy and Minimize Unnecessary Biopsies

FS Raza, SK Prasad, AI Saber, S Karna… - Open Journal of …, 2024 - scirp.org
To evaluate the effectiveness of PSA density in distinguishing between benign prostatic
hyperplasia (BPH) and prostate cancer in patients with intermediate PSA levels (4-10 ng/ml) …

[PDF][PDF] 基于多参数磁共振成像的PI-RADS 第二版评分联合f/t PSA 及PSAD 在前列腺癌早期筛查中的预测价值

陈秀凤, 卜庆丰, 张杰 - 岭南现代临床外科, 2021 - lingnanwaike.com
目的探讨基于多参数磁共振成像的PI⁃ RADS 第二版评分联合f/t PSA 及PSAD
在前列腺癌早期筛查中的预测价值. 方法回顾性分析2015 年1 月至2020 年12 月期间的289 …

[PDF][PDF] Comparison of Serum Microseminoprotein-Beta (MSMB) with Total Prostate Specific Antigen (TPSA) in the Diagnosis of Prostate Cancer in African Men

EU Oyibo - cancer - academia.edu
➢ Background The burden of prostate cancer is high globally and especially among men of
African descent. Serum prostate specific antigen (PSA) has long been used for diagnosis …